Regenxbio Inc (RGNX)

7.40 +0.02 (+0.27%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Regenxbio Cash and Short Term Investments (Quarterly): 255.46M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for RGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Catalyst Pharmaceuticals Inc 442.33M
Vertex Pharmaceuticals Inc 6.524B
Sarepta Therapeutics Inc 1.198B
Edgewise Therapeutics Inc 492.54M
Entrada Therapeutics Inc 449.34M